ホーム › 食道腺癌 › ニューヨーク › New York City
New York City、NYにおける食道腺癌の臨床試験
New York Cityとその周辺地域（約30マイル以内）の拠点で、食道腺癌に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
被験者募集中第2/3相
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
被験者募集中第3相
- Manhattan Eye Ear and Throat Hospital, New York
- NYP/Weill Cornell Medical Center, New York
- Lenox Hill Hospital, New York
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
被験者募集中第2/3相
- Memorial Sloan Kettering Cancer Center, New York
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
被験者募集中第1/2相
- Memorial Sloan-Kettering Cancer Center, New York
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
被験者募集中第2/3相
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- Rockefeller Outpatient Pavilion (53rd Street), New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
被験者募集中第1相
- Columbia University Irving Medical Center, New York
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
被験者募集中第2相
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction Adenocarcinoma
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
被験者募集中
- Columbia Universtiy, New York
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
被験者募集中第3相
- Research Site, New York
- Research Site, New York
- Research Site, New York
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
被験者募集中第1/2相
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
被験者募集中第1相
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
被験者募集中第1相
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
- Columbia University Irving Medical Center, New York
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
被験者募集中
- Weill Cornell Medicine, New York
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Research Site, New York
Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
被験者募集中第2相
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
他の都市における食道腺癌の試験
- Boston, MA13件の研究
- Houston, TX12件の研究
- Arlington, VA11件の研究
- Nashville, TN11件の研究
- Durham, NC10件の研究
- St. Louis, MO9件の研究
- Jacksonville, FL9件の研究
- Rochester, MN9件の研究
- Baldwin Park, CA9件の研究
- Queens, NY9件の研究
- Los Angeles, CA9件の研究
- Philadelphia, PA8件の研究
New York Cityにおける他の研究
- 乳がん136件の研究
- 非小細胞肺癌121件の研究
- がん（全種類）109件の研究
- 前立腺がん103件の研究
- 転移性癌93件の研究
- 大腸癌78件の研究
- 卵巣がん69件の研究
- 肺がん60件の研究
- 多発性骨髄腫60件の研究
- 膵臓がん60件の研究
- 子宮内膜がん52件の研究
- 急性骨髄性白血病51件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。